Literature DB >> 17474348

Disparities in cancer care: challenges and solutions.

Derek Raghavan1.   

Abstract

With regard to cancer management, minority populations do not fare as well as the majority in the U.S. health-care system. There is clear evidence of an increased incidence of cancer in minority populations, in many cases accompanied by reduced survival. Several factors appear to contribute to these differences, and the biomedical community has begun to focus on definining the scope of the problem and possible solutions. This review will address specific areas of disparity in cancer care, including prevention, diagnosis, treatment, and outcomes, and will consider steps toward resolving these issues.

Entities:  

Mesh:

Year:  2007        PMID: 17474348

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  9 in total

1.  Slow progress in cancer care disparities: HIPAA, PPACA, and CHEWBACCA... but we're still not there!

Authors:  Derek Raghavan
Journal:  Oncologist       Date:  2011

2.  Looking at cancer health disparities without the colored lenses.

Authors:  Mohammad Aslam Khan; Girijesh Kumar Patel; Sanjeev Kumar Srivastava; James Elliot Carter; Jennifer Young Pierce; Rodney Paul Rocconi; Seema Singh; Ajay Pratap Singh
Journal:  Cancer Health Disparities       Date:  2019-08-19

Review 3.  A Review of Barriers to Minorities' Participation in Cancer Clinical Trials: Implications for Future Cancer Research.

Authors:  Ali Salman; Claire Nguyen; Yi-Hui Lee; Tawna Cooksey-James
Journal:  J Immigr Minor Health       Date:  2016-04

4.  Survival disparities by Medicaid status: an analysis of 8 cancers.

Authors:  Siran M Koroukian; Paul M Bakaki; Derek Raghavan
Journal:  Cancer       Date:  2011-12-27       Impact factor: 6.860

Review 5.  Future cancer research priorities in the USA: a Lancet Oncology Commission.

Authors:  Elizabeth M Jaffee; Chi Van Dang; David B Agus; Brian M Alexander; Kenneth C Anderson; Alan Ashworth; Anna D Barker; Roshan Bastani; Sangeeta Bhatia; Jeffrey A Bluestone; Otis Brawley; Atul J Butte; Daniel G Coit; Nancy E Davidson; Mark Davis; Ronald A DePinho; Robert B Diasio; Giulio Draetta; A Lindsay Frazier; Andrew Futreal; Sam S Gambhir; Patricia A Ganz; Levi Garraway; Stanton Gerson; Sumit Gupta; James Heath; Ruth I Hoffman; Cliff Hudis; Chanita Hughes-Halbert; Ramy Ibrahim; Hossein Jadvar; Brian Kavanagh; Rick Kittles; Quynh-Thu Le; Scott M Lippman; David Mankoff; Elaine R Mardis; Deborah K Mayer; Kelly McMasters; Neal J Meropol; Beverly Mitchell; Peter Naredi; Dean Ornish; Timothy M Pawlik; Jeffrey Peppercorn; Martin G Pomper; Derek Raghavan; Christine Ritchie; Sally W Schwarz; Richard Sullivan; Richard Wahl; Jedd D Wolchok; Sandra L Wong; Alfred Yung
Journal:  Lancet Oncol       Date:  2017-10-31       Impact factor: 41.316

6.  Considerations of culture and social class for families facing cancer: the need for a new model for health promotion and psychosocial intervention.

Authors:  Catherine A Marshall; Linda K Larkey; Melissa A Curran; Karen L Weihs; Terry A Badger; Julie Armin; Francisco García
Journal:  Fam Syst Health       Date:  2011-06       Impact factor: 1.950

7.  Initial Results from Mobile Low-Dose Computerized Tomographic Lung Cancer Screening Unit: Improved Outcomes for Underserved Populations.

Authors:  Derek Raghavan; Mellisa Wheeler; Darcy Doege; John D Doty; Henri Levy; Kia A Dungan; Lauren M Davis; James M Robinson; Edward S Kim; Kathryn F Mileham; James Oliver; Daniel Carrizosa
Journal:  Oncologist       Date:  2019-11-26

Review 8.  Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines.

Authors:  R P Symonds; K Lord; A J Mitchell; D Raghavan
Journal:  Br J Cancer       Date:  2012-05-31       Impact factor: 7.640

9.  How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in California? Explaining the Hispanic paradox.

Authors:  Manali I Patel; Clayton W Schupp; Scarlett L Gomez; Ellen T Chang; Heather A Wakelee
Journal:  J Clin Oncol       Date:  2013-08-19       Impact factor: 50.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.